These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31721679)

  • 1. Re: Pigmentary Maculopathy Associated with Chronic Exposure to Pentosan Polysulfate Sodium.
    Wein AJ
    J Urol; 2020 Feb; 203(2):259-260. PubMed ID: 31721679
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Pearce et al.: Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium (Ophthalmology. 2018;125:1793-1802).
    Greenlee T; Hom G; Conti T; Babiuch AS; Singh R
    Ophthalmology; 2019 Jul; 126(7):e51. PubMed ID: 31229012
    [No Abstract]   [Full Text] [Related]  

  • 3. Maculopathy secondary to chronic use of pentosan polysulfate sodium in treatment of interstitial cystitis.
    Atanasoff TL; Schleis MN; Keller JA
    Clin Exp Optom; 2023 Sep; 106(7):803-805. PubMed ID: 36031934
    [No Abstract]   [Full Text] [Related]  

  • 4. Pentosan Polysulfate Maculopathy: What Urologists Should Know in 2020.
    Paredes Mogica JA; De EJB
    Urology; 2021 Jan; 147():109-118. PubMed ID: 33045286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Review - Proctor JG. Pentosan polysulfate and a pigmentary maculopathy: causation versus correlation?
    Foote J; Shiromani S; Jain N
    Can J Urol; 2024 Jun; 31(3):11867-11868. PubMed ID: 38912936
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Letter to the Editor - Proctor JG. Pentosan polysulfate and a pigmentary maculopathy: causation versus correlation?
    Proctor JG
    Can J Urol; 2024 Jun; 31(3):11869-11870. PubMed ID: 38912937
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Pentosan Polysulfate Maculopathy: What Urologists Should Know in 2020.
    Jain N
    Urology; 2021 Jun; 152():205-206. PubMed ID: 33493509
    [No Abstract]   [Full Text] [Related]  

  • 8. Pentosan polysulfate and a pigmentary maculopathy: causation versus correlation?
    Proctor JG
    Can J Urol; 2023 Dec; 30(6):11732-11739. PubMed ID: 38104330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentosan Polysulfate-Associated Macular Disease in Patients With Interstitial Cystitis.
    Lyons RJ; Ahmad S; Ansari S; Foote JE; Jain N
    Obstet Gynecol; 2020 May; 135(5):1091-1094. PubMed ID: 32282604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maculopathy caused by pentosan polysulfate.
    Rosenberg D; Sarraf D; Chaudhary V
    CMAJ; 2021 May; 193(18):E645. PubMed ID: 33941523
    [No Abstract]   [Full Text] [Related]  

  • 11. Age-Related Macular Degeneration Masquerade: A Review of Pentosan Polysulfate Maculopathy and Implications for Clinical Practice.
    Mukhopadhyay C; Boyce TM; Gehrs KM; Folk JC; Mullins RF; Luo Y; Kreder K; Sohn EH
    Asia Pac J Ophthalmol (Phila); 2022 Mar-Apr 01; 11(2):100-110. PubMed ID: 35533330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strength of Association between Pentosan Polysulfate and a Novel Maculopathy.
    Hanif AM; Shah R; Yan J; Varghese JS; Patel SA; Cribbs BE; O'Keefe G; Hendrick AM; Shantha JG; Hubbard GB; Patel PS; Rao P; Yeh S; Jain N
    Ophthalmology; 2019 Oct; 126(10):1464-1466. PubMed ID: 31004677
    [No Abstract]   [Full Text] [Related]  

  • 13. PENTOSAN POLYSULFATE SODIUM (ELMIRON) MACULOPATHY: A Genetic Perspective.
    Kalaw FGP; Ignacio JCI; Wu CY; Ferreyra H; Nudleman E; Baxter SL; Freeman WR; Borooah S
    Retina; 2023 Jul; 43(7):1174-1181. PubMed ID: 36996461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case Report: Pentosan Polysulfate Sodium Maculopathy Originally Diagnosed as Pattern Macular Dystrophy.
    Case AW; Anderson MJ; Sayomac LE
    Optom Vis Sci; 2021 Jun; 98(6):552-556. PubMed ID: 34039907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive Maculopathy After Discontinuation of Pentosan Polysulfate Sodium.
    Huckfeldt RM; Vavvas DG
    Ophthalmic Surg Lasers Imaging Retina; 2019 Oct; 50(10):656-659. PubMed ID: 31671200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentosan polysulfate maculopathy versus age-related macular degeneration: comparative assessment with multimodal imaging.
    Christiansen JS; Barnes AC; Berry DE; Jain N
    Can J Ophthalmol; 2022 Feb; 57(1):16-22. PubMed ID: 33722504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular Toxicity Associated With Pentosan Polysulfate Sodium.
    Astafurov KV; Bakri SJ; Barkmeier AJ
    Mayo Clin Proc; 2021 Jun; 96(6):1682-1684. PubMed ID: 34088428
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk of maculopathy with pentosan polysulfate sodium use.
    Bae SS; Sodhi M; Maberley D; Kezouh A; Etminan M
    Br J Clin Pharmacol; 2022 Jul; 88(7):3428-3433. PubMed ID: 35277990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentosan polysulfate sodium for treatment of interstitial cystitis/bladder pain syndrome: insights from a randomized, double-blind, placebo controlled study.
    Nickel JC; Herschorn S; Whitmore KE; Forrest JB; Hu P; Friedman AJ; Baseman AS
    J Urol; 2015 Mar; 193(3):857-62. PubMed ID: 25245489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanded Clinical Spectrum of Pentosan Polysulfate Maculopathy: A Macula Society Collaborative Study.
    Jain N; Liao A; Garg SJ; Patel SN; Wykoff CC; Yu HJ; London NJS; Khurana RN; Zacks DN;
    Ophthalmol Retina; 2022 Mar; 6(3):219-227. PubMed ID: 34298229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.